Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration (FDA) for marketing. more
| Time Frame | BBP | S&P500 |
|---|---|---|
| 1-Week Return | -2.46% | -1.29% |
| 1-Month Return | -1.36% | -0.18% |
| 3-Month Return | 9.32% | 3.32% |
| 6-Month Return | 33.93% | 21.12% |
| 1-Year Return | 51.47% | 15.32% |
| 3-Year Return | 109.9% | 79.17% |
| 5-Year Return | 107.8% | 76.14% |
| 10-Year Return | 220.66% | 256.96% |
| Time Frame | BBP | S&P500 |
|---|---|---|
| 1-Week Return | -72.71% | -49.19% |
| 1-Month Return | -15.35% | -2.17% |
| 3-Month Return | 43.53% | 14.16% |
| 6-Month Return | 80.83% | 47.48% |
| 1-Year Return | 51.47% | 15.32% |
| 3-Year Return | 28.04% | 21.46% |
| 5-Year Return | 15.75% | 11.99% |
| 10-Year Return | 12.36% | 13.57% |
| Stock name | Ticker | Weight |
|---|---|---|
Moderna Inc | MRNA | 5.03% |
Iovance Biotherapeutics Inc | IOVA | 3.41% |
Omeros Corp | OMER | 2.97% |
Verastem Inc | VSTM | 2.45% |
Precigen Inc | PGEN | 2.23% |
Halozyme Therapeutics Inc | HALO | 2.14% |
Zai Lab Ltd | ZLAB | 1.91% |
Rigel Pharmaceuticals Inc | RIGL | 1.88% |
Kiniksa Pharmaceuticals International Plc | KNSA | 1.87% |
BeOne Medicines Ltd | BGNE | 1.75% |
Xeris Biopharma Holdings Inc | XERS | 1.7% |
Regeneron Pharmaceuticals Inc | REGN | 1.68% |
Protagonist Therapeutics Inc | PTGX | 1.61% |
Insmed Inc | INSM | 1.6% |
Tarsus Pharmaceuticals Inc | TARS | 1.58% |
ImmunityBio Inc | IBRX | 1.57% |
Roivant Sciences Ltd | ROIV | 1.55% |
Sarepta Therapeutics Inc | SRPT | 1.55% |
Kura Oncology Inc | KURA | 1.55% |
Harmony Biosciences Holdings Inc | HRMY | 1.54% |
Novavax Inc | NVAX | 1.54% |
Gilead Sciences Inc | GILD | 1.54% |
Vertex Pharmaceuticals Inc | VRTX | 1.51% |
Zymeworks Inc | ZYME | 1.51% |
Ligand Pharmaceuticals Inc | LGND | 1.51% |
Travere Therapeutics Inc | TVTX | 1.5% |
Nuvation Bio Inc | NUVB | 1.5% |
TG Therapeutics Inc | TGTX | 1.5% |
ADMA Biologics Inc | ADMA | 1.49% |
Ironwood Pharmaceuticals Inc | IRWD | 1.48% |
Incyte Corp | INCY | 1.48% |
Amgen Inc | AMGN | 1.47% |
Biogen Inc | BIIB | 1.46% |
CRISPR Therapeutics AG | CRSP | 1.44% |
Agios Pharmaceuticals Inc | AGIO | 1.44% |
Rhythm Pharmaceuticals Inc | RYTM | 1.43% |
BioMarin Pharmaceutical Inc | BMRN | 1.41% |
BioNTech SE | BNTX | 1.41% |
Geron Corp | GERN | 1.41% |
Exelixis Inc | EXEL | 1.41% |
Krystal Biotech Inc | KRYS | 1.4% |
Immunocore Holdings PLC | IMCR | 1.39% |
Arcutis Biotherapeutics Inc | ARQT | 1.39% |
Madrigal Pharmaceuticals Inc | MDGL | 1.38% |
Ascendis Pharma A/S | ASND | 1.36% |
ACADIA Pharmaceuticals Inc | ACAD | 1.35% |
Aurinia Pharmaceuticals Inc | AUPH | 1.35% |
Liquidia Corp | LQDA | 1.28% |
Bridgebio Pharma Inc | BBIO | 1.28% |
Syndax Pharmaceuticals Inc | SNDX | 1.27% |
BioCryst Pharmaceuticals Inc | BCRX | 1.26% |
Denali Therapeutics Inc | DNLI | 1.22% |
Cytokinetics Inc | CYTK | 1.21% |
Mirum Pharmaceuticals Inc | MIRM | 1.16% |
Arrowhead Pharmaceuticals Inc | ARWR | 1.14% |
Alnylam Pharmaceuticals Inc | ALNY | 1.14% |
Neurocrine Biosciences Inc | NBIX | 1.12% |
United Therapeutics Corp | UTHR | 1.11% |
PTC Therapeutics Inc | PTCT | 1.07% |
Axsome Therapeutics Inc | AXSM | 0.99% |
Phathom Pharmaceuticals Inc | PHAT | 0.88% |
Ultragenyx Pharmaceutical Inc | RARE | 0.78% |
Ardelyx Inc | ARDX | 0.78% |
Ionis Pharmaceuticals Inc | IONS | 0.77% |
Legend Biotech Corp | LEGN | 0.68% |
Cash/Cash equivalents | Cash.Cash.equivalents | 0.25% |
OmniAb Inc | OmniAb.Inc | 0% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
Virtus LifeSci Biotech Products ETF (BBP) share price today is $106.2864.
Yes, Indians can buy shares of Virtus LifeSci Biotech Products ETF (BBP) on Vested. To buy BBP from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Virtus LifeSci Biotech Products ETF (BBP) on Vested. You can start investing in Virtus LifeSci Biotech Products ETF (BBP) with a minimum investment of $1.
The 52-week high price of Virtus LifeSci Biotech Products ETF (BBP) is $110.05. The 52-week low price of Virtus LifeSci Biotech Products ETF (BBP) is $70.27.
The stock symbol (or ticker) of Virtus LifeSci Biotech Products ETF is BBP.
Yes, you can setup SIP in Virtus LifeSci Biotech Products ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of BBP on the Vested app.
The expense ratio of Virtus LifeSci Biotech Products ETF (BBP) is 0.79%.
Link copied